Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Cancer Science|May 13, 2022
IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cellsHuihui Xiang, Yujiro Toyoshima, Weidong Shen, et al.
Head & Neck|March 29, 2025
Differences in PD-L1, PD-L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective StudyRyosuke Sato, Takahiro Inoue, Risa Wakisaka, et al.
Clinical Case Reports|December 31, 2014
Oral infection control to assist infliximab therapy in a Behçet's disease patient with severe eye inflammation in response to dental treatment: a case reportChieko Kudo, Hiroshi Wakabayashi, Masayuki Shimoe, et al.
Oncoimmunology|December 5, 2018
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinomaKenzo Ohara, Takayuki Ohkuri, Takumi Kumai, et al.
Heliyon|December 7, 2018
Fungal metabolite (+)-terrein suppresses IL-6/sIL-6R-induced CSF1 secretion by inhibiting JAK1 phosphorylation in human gingival fibroblastsSatoshi Yamamoto, Kazuhiro Omori, Hiroki Mandai, et al.
Immunological Medicine|January 18, 2024
NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike proteinAiko Murai, Terufumi Kubo, Takayuki Ohkuri, et al.
Cancers|September 14, 2024
Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck CancerRisa Wakisaka, Hidekiyo Yamaki, Michihisa Kono, et al.
Head & Neck|February 23, 2024
Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancerMichihisa Kono, Risa Wakisaka, Hiroki Komatsuda, et al.
Oncoimmunology|July 30, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapyKei Ishibashi, Takumi Kumai, Takayuki Ohkuri, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphomaToshihiro Nagato, Seigo Ueda, Miki Takahara, et al.
Pageof 10